Top Markets
Coin of the day
OKYO Pharma Limited OKYO Pharma Limited

OKYO Pharma Limited

OKYO
Rangering i aksjer #39874
OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical... OKYO Pharma Limited, a biopharmaceutical entity operating at the preclinical stage, focuses on creating treatments for individuals experiencing inflammatory conditions of the eye and chronic ocular pain. Established in 2007 and headquartered in London, UK, the company's primary investigational drug is OK-101, aimed at addressing dry eye syndrome. Additionally, the firm is advancing OK-201, a preclinical analogue developed from bovine adrenal medulla, designed to alleviate neuropathic ocular pain.
Aksjekurs
$0.01904982
Sist synkronisert: 2023-05-19
Markedsverdi
$316.00K
Endring (1 dag)
-17.05%
Endring (1 år)
0.00%
Land
GB
Handel OKYO Pharma Limited (OKYO)

Kategori

Aksjeprishistorikk for OKYO Pharma Limited (OKYO)
Høyeste sluttskurs: $0.02 den 2023-05-01

Laveste sluttskurs: $0.07 den 2018-07-01
Aksjeprishistorikk for OKYO Pharma Limited fra 2018 til 2026
Årlig aksjeprisytelse
År Ytelse
2023 -21.40%
2022 -68.15%
2021 -2.30%
2020 334.44%
2019 25.96%
2018 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.40%
KR
$259.89 14.81%
BE